A Comprehensive Review on Pharmaceutical Film Coating: Past, Present, and Future

References

• AugsburgerLL, HoagSW. Pharmaceutical Dosage Forms-Tablets. CRC press; 2016.
   Google Scholar
• SastrySV, NyshadhamJR, FixJA. Recent technological advances in oral drug delivery–a review. Pharm Sci Technolo Today. 2000;3(4):138–145.
   PubMedGoogle Scholar
• RemingtonJP. Remington: The Science and Practice of Pharmacy. Vol. 1 Lippincott Williams & Wilkins; 2006.
   Google Scholar
• PorterSC. Coating of tablets and multiparticulates In: AultonME, editor. Pharmaceutics. The Design and Manufacture of Medicines. 3rd ed. Churchill Livingstone: Elsevier; 2007:500–514.
   Google Scholar
• BoseS, BognerRH. Solventless pharmaceutical coating processes: a review. Pharm Dev Technol. 2007;12(2):115–131. doi:10.1080/1083745070121247917510883
   PubMed Web of Science ®Google Scholar
• SuganyaV, AnuradhaV. Microencapsulation and nanoencapsulation: a review. Int J Pharm Clin Res. 2017;9(3):233–239. doi:10.25258/ijpcr.v9i3.8324
   Google Scholar
• PauloF, SantosL. Design of experiments for microencapsulation applications: a review. Mater Sci Eng C. 2017;77:1327–1340. doi:10.1016/j.msec.2017.03.219
   PubMed Web of Science ®Google Scholar
• ElderD. Design, formulation and manufacture of film-coated drug products. Eur Pharm Rev. 2017;22(5):37–40.
   Google Scholar
• DelwicheJ. The impact of perceptual interactions on perceived flavor. Food Qual Prefer. 2004;15(2):137–146. doi:10.1016/S0950-3293(03)00041-7
   Web of Science ®Google Scholar
• SrivastavaR, MoreAT. Some aesthetic considerations for over the-counter (OTC) pharmaceutical products. Int J Biotechnol. 2010;11(3–4):267–283. doi:10.1504/IJBT.2010.036600
   Google Scholar
• LiuF, RanmalS, BatchelorHK, et al. Patient-centered pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871–1889.25274536
   PubMed Web of Science ®Google Scholar
• HealthUD, et al. Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules Guidance for Industry. 2015.
   Google Scholar
• SohiH, SultanaY, KharRK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm. 2004;30(5):429–448.15244079
   PubMed Web of Science ®Google Scholar
• AkreHS, MundhadaDR, BhaskaranS, AsgharS, GandhiGSet al. Dry suspension formulation of taste masked antibiotic drug for pediatric use. J Appl Pharm Sci. 2012;2(7):166.
   Google Scholar
• ShenRW, Taste masking of ibuprofen by fluid bed coating. Google Patents 1996.
   Google Scholar
• GergelyG, GergelyT, GergelyI. Pharmaceutical Preparation in the form of an effervescent and/or disintegrating tablet or an instant granule and process of producing it. PCT Int Appl. 1993;WO9313760.
   Google Scholar
• RocheEJ, Taste masking and sustained release coatings for pharmaceuticals. Google Patents. 1991.
   Google Scholar
• RocheEJ, ReoJP, Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets. Google Patents. 1994.
   Google Scholar
• WatermanKC, MacDonaldBC. Package selection for moisture protection for solid, oral drug products. J Pharm Sci. 2010;99(11):4437–4452. doi:10.1002/jps.2216120845442
   PubMed Web of Science ®Google Scholar
• BowenL, ManganM, HaywoodA, GlassB. Stability of frusemide tablets repackaged in dose administration aids. J Pharm Pract Res. 2007;37(3):178–181.
   Google Scholar
• Raimi‐AbrahamBT, et al. Investigating the physical stability of repackaged medicines stored into commercially available multicompartment compliance aids (MCAs). J Pharm Health Serv Res. 2017;8(2):81–89.28713440
   PubMedGoogle Scholar
• BurkeMD, HeX, CookC, et al. Stability enhancement of drug layered pellets in a fixed dose combination tablet. Aaps Pharmscitech. 2013;14(1):312–320. doi:10.1208/s12249-012-9911-323319298
   PubMed Web of Science ®Google Scholar
• ModiF, PatelP. Formulation, optimization evaluation of fixed dose combination moisture barrier film coated bilayer tablet of artesunate & amodiaquine hydrochloride. Int J PharmTech. 2011;3:2124–2134.
   Google Scholar
• ParmarK, BhattNM, PathakNL, et al. An overview: aqueous film coating technology on tablets. Int J Pharm Chem Sci. 2012;1(3):994–1001.
   Google Scholar
• GuidelineIHT. Impurities: guideline for residual solvents Q3C (R5). Current Step. 2005;4:1–25.
   Google Scholar
• ObaraS, MaruyamaN, NishiyamaY, et al. Dry coating: an innovative enteric coating method using a cellulose derivative. Eur J Pharm Biopharm. 1999;47(1):51–59. doi:10.1016/S0939-6411(98)00087-310234527
   PubMed Web of Science ®Google Scholar
• BechardS, QuraishiO, KwongE. Film coating: effect of titanium dioxide concentration and film thickness on the photostability of nifedipine. Int J Pharm. 1992;87(1–3):133–139. doi:10.1016/0378-5173(92)90236-U
   Web of Science ®Google Scholar
• BaertschiSW, AlsanteKM, TønnesenHH. A critical assessment of the ICH guideline on photostability testing of new drug substances and products (Q1B): recommendation for revision. J Pharm Sci. 2010;99(7):2934–2940. doi:10.1002/jps.2207620135694
   PubMed Web of Science ®Google Scholar
• MukharyaA, PatelPU, ChaudharyS. Effect assessment of “film coating and packaging” on the photo-stability of highly photo-labile antihypertensive products. Int J Pharm Investig. 2013;3(2):77. doi:10.4103/2230-973X.114903
   PubMedGoogle Scholar
• FeltonLA, PorterSC. An update on pharmaceutical film coating for drug delivery. Expert Opin Drug Deliv. 2013;10(4):421–435.23339342
   PubMed Web of Science ®Google Scholar
• AshtonP, ChenJ, GuoH, Polymer-based, sustained release drug delivery system. Google Patents. 2009.
   Google Scholar
• ZaidAN, QaddomiA. Development and stability evaluation of enteric coated Diclofenac sodium tablets using Sureteric. Pak J Pharm Sci. 2012;25:1.22186302
   PubMed Web of Science ®Google Scholar
• ZaidAN, NatourS, GhoushA, et al. Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry® yellow 20A82938 on an industrial scale. Drug Des Devel Ther. 2013;7:83. doi:10.2147/DDDT.S37369
   PubMed Web of Science ®Google Scholar
• ZaidA, FaddaAM, NatorS, et al. Development and stability evaluation of enteric coated diclofenac sodium tablets using AquaPolish E. J Pharm Invest. 2011;41(4):211–215. doi:10.4333/KPS.2011.41.4.211
   Google Scholar
• FlößerA, KolterK, ReichH-B, et al. Variation of composition of an enteric formulation based on Kollicoat MAE 30 D. Drug Dev Ind Pharm. 2000;26(2):177–187. doi:10.1081/DDC-10010034210697754
   PubMed Web of Science ®Google Scholar
• FeltonL, HaaseMM, ShahNH, et al. Physical and enteric properties of soft gelatin capsules coated with eudragit ® L 30 D-55. Int J Pharm. 1995;113(1):17–24. doi:10.1016/0378-5173(94)00169-6
   Web of Science ®Google Scholar
• ParkHJ, JungHJ, HoMJ, et al. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet. Eur J Pharm Sci. 2017;102:172–179. doi:10.1016/j.ejps.2017.03.00628279763
   PubMed Web of Science ®Google Scholar
• HowdenCW. Update on dual delayed-release PPI formulations. Gastroenterol Hepatol (N Y). 2010;6(7):417.20827362
   PubMedGoogle Scholar
• MaroniA, MoutaharrikS, ZemaL, GazzanigaA. Enteric Coatings for Colonic Drug Delivery: State of the Art. Taylor & Francis; 2017.
   Google Scholar
• IbekweV, KhelaMK, EvansDF, BasitAW. A new concept in colonic drug targeting: a combined pH‐responsive and bacterially‐triggered drug delivery technology. 2008;28(7):911–916.
   Google Scholar
• LiuF, MorenoP, BasitAW. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract. Eur J Pharm Biopharm. 2010;74(2):311–315. doi:10.1016/j.ejpb.2009.11.00819932177
   PubMed Web of Science ®Google Scholar
• VarumF, HattonGB, FreireAC, et al. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy. Eur J Pharm Biopharm. 2013;84(3):573–577. doi:10.1016/j.ejpb.2013.01.00223348235
   PubMed Web of Science ®Google Scholar
• SchellekensR, StellaardF, MitrovicD, et al. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. J Controlled Release. 2008;132(2):91–98.
   PubMed Web of Science ®Google Scholar
• SchellekensR, StellaardF, et al. Oral ileocolonic drug delivery by the colopulse-system: a bioavailability study in healthy volunteers. J Controlled Release. 2010;146(3):334–340.
   PubMed Web of Science ®Google Scholar
• TangES, ChanL, P Heng. Coating of Multiparticulates for Sustained Release. Am J Drug Delivery. 2005;3(1):17–28.
   Google Scholar
• RoyP, ShahiwalaA. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. 2009;134(2):74–80.
   Google Scholar
• SiepmannF, et al. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. 2007;119(2):182–189.
   Google Scholar
• LotlikarV, KedarU, ShidhayeS, KadamV. pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis. Drug Devel Ind Pharm. 2010;36(11):1295–1302.20849346
   PubMed Web of Science ®Google Scholar
• LecomteF, SiepmannJ, WaltherM, MacRaeRJ, BodmeierR. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques. 2004;21(5):882–890.
   Google Scholar
• DashevskyA, MohamadP. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat®. ECD. 2006;318(1–2):124–131.
   Google Scholar
• LevinaM, VuongH, Rajabi-SiahboomiAR. The influence of hydro-alcoholic media on hypromellose matrix systems. Drug Dev Ind Pharm. 2007;33(10):1125–1134. doi:10.1080/0363904070137786217963114
   PubMed Web of Science ®Google Scholar
• AvachatAM, NandareDS. Effect of alcohol on drug release kinetics from HPMC-based matrix tablets using model drugs. Dissolut Technol. 2014;21:11–17.
   Web of Science ®Google Scholar
• AnnTPFFA, HebestreitGKHJ-P, FahamYRMYA, Regulatory Considerations for Alcohol-Induced Dose Dumping of Oral Modified-Release Formulations. 2015.
   Google Scholar
• FaddaHM, MohamedMA, BasitAW. Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol. Int J Pharm. 2008;360(1–2):171–176. doi:10.1016/j.ijpharm.2008.04.03518547758
   PubMed Web of Science ®Google Scholar
• D’SouzaS, MayockS, SaltA. A review of in vivo and in vitro aspects of alcohol-induced dose dumping. AAPS Open. 2017;3(1):1–20. doi:10.1186/s41120-017-0014-9
   Google Scholar
• MinerP Jr, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole: a five-way crossover study the . Am J Gastroenterol. 2003;98(12):2616–2620.14687806
   PubMed Web of Science ®Google Scholar
• ThakralS, ThakralNK, MajumdarDK. Eudragit®: a technology evaluation. Expert Opin Drug Deliv. 2013;10(1):131–149.23102011
   PubMed Web of Science ®Google Scholar
• D’SouzaS, MayockS, SaltA. A review of in vivo and in vitro aspects of alcohol-induced dose dumping. AAPS Open. 2017;3(1):1–20.
   Google Scholar
• PorterS, SackettG, LiuL. Development, Optimization, and Scale-Up of Process Parameters: Pan Coating, in Developing Solid Oral Dosage Forms. Elsevier; 2017:953–996.
   Google Scholar
• PorterSC, Preventing Film Coating Problems by Design. 2016.
   Google Scholar
• MayRK, EvansMJ, ZhongS, et al. Terahertz in-line sensor for direct coating thickness measurement of individual tablets during film coating in real-time. J Pharm Sci. 2011;100(4):1535–1544. doi:10.1002/jps.2235920957746
   PubMed Web of Science ®Google Scholar
• KorasaK, HudovornikG, VrečerF. Applicability of near-infrared spectroscopy in the monitoring of film coating and curing process of the prolonged release coated pellets. Eur J Pharm Sci. 2016;93:484–492.27562707
   PubMed Web of Science ®Google Scholar
• LiM, SanderS, DuanJ, et al. Scientific and regulatory considerations in solid oral modified release drug product development. AAPS J. 2016;18(6):1406–1417. doi:10.1208/s12248-016-9974-227650190
   PubMed Web of Science ®Google Scholar
• KramarA, TurkS, VrečerF. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm. 2003;256(1–2):43–52.12695010
   PubMed Web of Science ®Google Scholar
• NutanMT, SolimanMS, TahaEI, et al. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate. Int J Pharm. 2005;294(1–2):89–101. doi:10.1016/j.ijpharm.2005.01.01315814233
   PubMed Web of Science ®Google Scholar
• FerreiraAP, TobynM. Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era. Pharm Dev Technol. 2015;20(5):513–527. doi:10.3109/10837450.2014.89865624641280
   PubMed Web of Science ®Google Scholar
• Perez-RamosJD. Monitoring and Modeling of Film Coating in a Side Vented Pan Coater Using Near-Infrared Reflectance Spectroscopy, Digital Video Imaging and Computational Methods. Purdue University; 2007.
   Google Scholar
• CunninghamC, HansellJ, Nuneviller IIIF, et al. Evaluation of recent advances in continuous film coating processes. Drug Dev Ind Pharm. 2010;36(2):227–233. doi:10.3109/0363904090341032619954403
   PubMed Web of Science ®Google Scholar
• WirgesM, FunkeA, SernoP, et al. Development and in-line validation of a process analytical technology to facilitate the scale up of coating processes. J Pharm Biomed Anal. 2013;78:57–64. doi:10.1016/j.jpba.2013.01.03723454678
   PubMed Web of Science ®Google Scholar
• PrasadLK, McGinityJW, WilliamsRO. III, Electrostatic powder coating: principles and pharmaceutical applications. Int J Pharm. 2016;505(1–2):289–302. doi:10.1016/j.ijpharm.2016.04.01627085644
   PubMed Web of Science ®Google Scholar
• QiaoM, ZhangL, MaY, ZhuJ, ChowK. A novel electrostatic dry powder coating process for pharmaceutical dosage forms: immediate release coatings for tablets. Eur J Pharm Biopharm. 2010;76(2):304–310.20600889
   PubMed Web of Science ®Google Scholar
• TsintaviE, RekkasDM, BettiniP, Partial tablet coating by 3D printing. 2020: 119298.
   Google Scholar
• KapoorD, et al. Coating Technologies in Pharmaceutical Product Development, in Drug Delivery Systems. Vol. 2020 Elsevier: 665–719.
   Google Scholar